ResearcherUniversity Hospital UlmActive in the last 2 years

Ali M. Kassem

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1820-8518; OpenAlex author ID A5072205248. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression. Co-author DOI 10.1038/s41420-026-03174-z ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hend Abdelrasoul · 1 shared paper, 2026 · strength 0.24
- Paper Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression. DOI 10.1038/s41420-026-03174-z ↗
Nuh N. Rahbari · 1 shared paper, 2026 · strength 0.24
- Paper Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression. DOI 10.1038/s41420-026-03174-z ↗
Thomas Wirth · 1 shared paper, 2026 · strength 0.24
- Paper Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression. DOI 10.1038/s41420-026-03174-z ↗
Bo Kong · 1 shared paper, 2026 · strength 0.24
- Paper Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression. DOI 10.1038/s41420-026-03174-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.